1、(a joint stock limited company incorporated in the Peoples Republic of China with limited liability)*For identifcation purposes only(在中華人民共和國註冊成立的股份有限公司)(Stock Code 股票號碼僅供識別:1066)ENVIRONMENTAL,SOCIAL AND GOVERNANCE REPORT 2024環境、社會及管治報告ENVIRONMENTAL,SOCIAL AND GOVERNANCE REPORT環境、社會及管治報告1CONTENTS目錄P
2、age頁數I.ABOUT THE REPORT一、關於本報告2II.ESG MANAGEMENT二、環境、社會及管治的管理4III.ENVIRONMENTAL PROTECTION三、環境保護191.Management of Emissions1.排放物的管理202.Management of Resources Utilisation2.資源使用的管理273.The Environment and Natural Resources3.環境及天然資源394.Climate Change4.氣候變化40IV.EMPLOYMENT AND LABOUR PRACTICES四、僱傭及勞工常規42
3、1.Employment1.僱傭432.Health and Safety2.健康與安全513.Development and Training3.發展及培訓594.Labour Standards4.勞工準則63V.OPERATING PRACTICES五、營運慣例651.Supply Chain Management1.供應鏈管理652.Product Responsibility2.產品責任673.Anti-corruption3.反貪污75VI.COMMUNITY INVESTMENT六、社區投資77VII.“ENVIRONMENTAL,SOCIAL AND GOVERNANCE RE
4、PORTING CODE”BY THE HKEX七、聯交所 環境、社會及管治報告守則 內容索引79ENVIRONMENTAL,SOCIAL AND GOVERNANCE REPORT環境、社會及管治報告2SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITEDENVIRONMENTAL,SOCIAL AND GOVERNANCE REPORT 2024山東威高集團醫用高分子製品股份有限公司2024 環境、社會及管治報告I.ABOUT THE REPORTOverviewThe Board of Directors(the“Board”)of S
5、handong Weigao Group Medical Polymer Company Limited(the“Company”)is pleased to present this Environmental,Social and Governance(hereinafter called“ESG”)Report(the“Report”)of the Company and its subsidiaries(collectively as the“Group”)for the year ended 31 December 2024(the“Reporting Period”).The Re
6、port details the Groups relevant policies,strategies,management approaches,and specific measures in the areas of environmental and social sustainability,and reports on the Groups performance in these regards.Reporting ScopeThe Report covers the Groups manufacturing business of medical consumables,or